While multiple studies have also found that semaglutide reduces the risk of death
New research suggests the anti-obesity drug Ozempic could slow down ageing.
Multiple studies have also found semaglutide reduces the risk of death in people who are obese and have heart disease without diabetes.
Participants who took the drug died at a lower rate from all causes - in a study of over 17 thousand over 45s.